Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia

Atsuya Yamashita, Kazi Abdus Salam, Atsushi Furuta, Yasuyoshi Matsuda, Osamu Fujita, Hidenori Tani, Yoshihisa Fujita, Yuusuke Fujimoto, Masanori Ikeda, Nobuyuki Kato, Naoya Sakamoto, Shinya Maekawa, Nobuyuki Enomoto, Masamichi Nakakoshi, Masayoshi Tsubuki, Yuji Sekiguchi, Satoshi Tsuneda, Nobuyoshi Akimitsu, Naohiro Noda, Junichi TanakaKohji Moriishi

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    Hepatitis C virus (HCV) is a causative agent of acute and chronic hepatitis, leading to the development of hepatic cirrhosis and hepatocellular carcinoma. We prepared extracts from 61 marine organisms and screened them by an in vitro fluorescence assay targeting the viral helicase (NS3), which plays an important role in HCV replication, to identify effective candidates for anti-HCV agents. An ethyl acetate-soluble fraction of the feather star Alloeocomatella polycladia exhibited the strongest inhibition of NS3 helicase activity, with an IC50 of 11.7 μg/mL. The extract of A. polycladia inhibited interaction between NS3 and RNA but not ATPase of NS3. Furthermore, the replication of the replicons derived from three HCV strains of genotype 1b in cultured cells was suppressed by the extract with an EC50 value of 23 to 44 μg/mL, which is similar to the IC50 value of the NS3 helicase assay. The extract did not induce interferon or inhibit cell growth. These results suggest that the unknown compound(s) included in A. polycladia can inhibit HCV replication by suppressing the helicase activity of HCV NS3. This study may present a new approach toward the development of a novel therapy for chronic hepatitis C.

    Original languageEnglish
    Pages (from-to)744-761
    Number of pages18
    JournalMarine Drugs
    Volume10
    Issue number4
    DOIs
    Publication statusPublished - 2012 Apr

    Fingerprint

    Feathers
    Virus Replication
    Hepacivirus
    Inhibitory Concentration 50
    Aquatic Organisms
    Replicon
    Chronic Hepatitis C
    Chronic Hepatitis
    Liver Cirrhosis
    Interferons
    Adenosine Triphosphatases
    ethyl acetate
    Hepatocellular Carcinoma
    Cultured Cells
    Fluorescence
    Genotype
    RNA
    Growth

    Keywords

    • Alloeocomatella polycladia
    • Hepatitis C virus
    • Marine organism
    • NS3 helicase

    ASJC Scopus subject areas

    • Drug Discovery

    Cite this

    Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia. / Yamashita, Atsuya; Salam, Kazi Abdus; Furuta, Atsushi; Matsuda, Yasuyoshi; Fujita, Osamu; Tani, Hidenori; Fujita, Yoshihisa; Fujimoto, Yuusuke; Ikeda, Masanori; Kato, Nobuyuki; Sakamoto, Naoya; Maekawa, Shinya; Enomoto, Nobuyuki; Nakakoshi, Masamichi; Tsubuki, Masayoshi; Sekiguchi, Yuji; Tsuneda, Satoshi; Akimitsu, Nobuyoshi; Noda, Naohiro; Tanaka, Junichi; Moriishi, Kohji.

    In: Marine Drugs, Vol. 10, No. 4, 04.2012, p. 744-761.

    Research output: Contribution to journalArticle

    Yamashita, A, Salam, KA, Furuta, A, Matsuda, Y, Fujita, O, Tani, H, Fujita, Y, Fujimoto, Y, Ikeda, M, Kato, N, Sakamoto, N, Maekawa, S, Enomoto, N, Nakakoshi, M, Tsubuki, M, Sekiguchi, Y, Tsuneda, S, Akimitsu, N, Noda, N, Tanaka, J & Moriishi, K 2012, 'Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia', Marine Drugs, vol. 10, no. 4, pp. 744-761. https://doi.org/10.3390/md10040744
    Yamashita, Atsuya ; Salam, Kazi Abdus ; Furuta, Atsushi ; Matsuda, Yasuyoshi ; Fujita, Osamu ; Tani, Hidenori ; Fujita, Yoshihisa ; Fujimoto, Yuusuke ; Ikeda, Masanori ; Kato, Nobuyuki ; Sakamoto, Naoya ; Maekawa, Shinya ; Enomoto, Nobuyuki ; Nakakoshi, Masamichi ; Tsubuki, Masayoshi ; Sekiguchi, Yuji ; Tsuneda, Satoshi ; Akimitsu, Nobuyoshi ; Noda, Naohiro ; Tanaka, Junichi ; Moriishi, Kohji. / Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia. In: Marine Drugs. 2012 ; Vol. 10, No. 4. pp. 744-761.
    @article{c487d7b729324f799a4f222d1abe3c49,
    title = "Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia",
    abstract = "Hepatitis C virus (HCV) is a causative agent of acute and chronic hepatitis, leading to the development of hepatic cirrhosis and hepatocellular carcinoma. We prepared extracts from 61 marine organisms and screened them by an in vitro fluorescence assay targeting the viral helicase (NS3), which plays an important role in HCV replication, to identify effective candidates for anti-HCV agents. An ethyl acetate-soluble fraction of the feather star Alloeocomatella polycladia exhibited the strongest inhibition of NS3 helicase activity, with an IC50 of 11.7 μg/mL. The extract of A. polycladia inhibited interaction between NS3 and RNA but not ATPase of NS3. Furthermore, the replication of the replicons derived from three HCV strains of genotype 1b in cultured cells was suppressed by the extract with an EC50 value of 23 to 44 μg/mL, which is similar to the IC50 value of the NS3 helicase assay. The extract did not induce interferon or inhibit cell growth. These results suggest that the unknown compound(s) included in A. polycladia can inhibit HCV replication by suppressing the helicase activity of HCV NS3. This study may present a new approach toward the development of a novel therapy for chronic hepatitis C.",
    keywords = "Alloeocomatella polycladia, Hepatitis C virus, Marine organism, NS3 helicase",
    author = "Atsuya Yamashita and Salam, {Kazi Abdus} and Atsushi Furuta and Yasuyoshi Matsuda and Osamu Fujita and Hidenori Tani and Yoshihisa Fujita and Yuusuke Fujimoto and Masanori Ikeda and Nobuyuki Kato and Naoya Sakamoto and Shinya Maekawa and Nobuyuki Enomoto and Masamichi Nakakoshi and Masayoshi Tsubuki and Yuji Sekiguchi and Satoshi Tsuneda and Nobuyoshi Akimitsu and Naohiro Noda and Junichi Tanaka and Kohji Moriishi",
    year = "2012",
    month = "4",
    doi = "10.3390/md10040744",
    language = "English",
    volume = "10",
    pages = "744--761",
    journal = "Marine Drugs",
    issn = "1660-3397",
    publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
    number = "4",

    }

    TY - JOUR

    T1 - Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia

    AU - Yamashita, Atsuya

    AU - Salam, Kazi Abdus

    AU - Furuta, Atsushi

    AU - Matsuda, Yasuyoshi

    AU - Fujita, Osamu

    AU - Tani, Hidenori

    AU - Fujita, Yoshihisa

    AU - Fujimoto, Yuusuke

    AU - Ikeda, Masanori

    AU - Kato, Nobuyuki

    AU - Sakamoto, Naoya

    AU - Maekawa, Shinya

    AU - Enomoto, Nobuyuki

    AU - Nakakoshi, Masamichi

    AU - Tsubuki, Masayoshi

    AU - Sekiguchi, Yuji

    AU - Tsuneda, Satoshi

    AU - Akimitsu, Nobuyoshi

    AU - Noda, Naohiro

    AU - Tanaka, Junichi

    AU - Moriishi, Kohji

    PY - 2012/4

    Y1 - 2012/4

    N2 - Hepatitis C virus (HCV) is a causative agent of acute and chronic hepatitis, leading to the development of hepatic cirrhosis and hepatocellular carcinoma. We prepared extracts from 61 marine organisms and screened them by an in vitro fluorescence assay targeting the viral helicase (NS3), which plays an important role in HCV replication, to identify effective candidates for anti-HCV agents. An ethyl acetate-soluble fraction of the feather star Alloeocomatella polycladia exhibited the strongest inhibition of NS3 helicase activity, with an IC50 of 11.7 μg/mL. The extract of A. polycladia inhibited interaction between NS3 and RNA but not ATPase of NS3. Furthermore, the replication of the replicons derived from three HCV strains of genotype 1b in cultured cells was suppressed by the extract with an EC50 value of 23 to 44 μg/mL, which is similar to the IC50 value of the NS3 helicase assay. The extract did not induce interferon or inhibit cell growth. These results suggest that the unknown compound(s) included in A. polycladia can inhibit HCV replication by suppressing the helicase activity of HCV NS3. This study may present a new approach toward the development of a novel therapy for chronic hepatitis C.

    AB - Hepatitis C virus (HCV) is a causative agent of acute and chronic hepatitis, leading to the development of hepatic cirrhosis and hepatocellular carcinoma. We prepared extracts from 61 marine organisms and screened them by an in vitro fluorescence assay targeting the viral helicase (NS3), which plays an important role in HCV replication, to identify effective candidates for anti-HCV agents. An ethyl acetate-soluble fraction of the feather star Alloeocomatella polycladia exhibited the strongest inhibition of NS3 helicase activity, with an IC50 of 11.7 μg/mL. The extract of A. polycladia inhibited interaction between NS3 and RNA but not ATPase of NS3. Furthermore, the replication of the replicons derived from three HCV strains of genotype 1b in cultured cells was suppressed by the extract with an EC50 value of 23 to 44 μg/mL, which is similar to the IC50 value of the NS3 helicase assay. The extract did not induce interferon or inhibit cell growth. These results suggest that the unknown compound(s) included in A. polycladia can inhibit HCV replication by suppressing the helicase activity of HCV NS3. This study may present a new approach toward the development of a novel therapy for chronic hepatitis C.

    KW - Alloeocomatella polycladia

    KW - Hepatitis C virus

    KW - Marine organism

    KW - NS3 helicase

    UR - http://www.scopus.com/inward/record.url?scp=84860616119&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84860616119&partnerID=8YFLogxK

    U2 - 10.3390/md10040744

    DO - 10.3390/md10040744

    M3 - Article

    C2 - 22690141

    AN - SCOPUS:84860616119

    VL - 10

    SP - 744

    EP - 761

    JO - Marine Drugs

    JF - Marine Drugs

    SN - 1660-3397

    IS - 4

    ER -